EIPCX
Price
$7.09
Change
+$0.02 (+0.28%)
Updated
Feb 4 closing price
Net Assets
2.64B
SKRRX
Price
$6.41
Change
+$0.05 (+0.79%)
Updated
Feb 4 closing price
Net Assets
846.46M
Interact to see
Advertisement

EIPCX vs SKRRX

Header iconEIPCX vs SKRRX Comparison
Open Charts EIPCX vs SKRRXBanner chart's image
Parametric Commodity Strategy I
Price$7.09
Change+$0.02 (+0.28%)
VolumeN/A
Net Assets2.64B
DWS Enhanced Commodity Strategy R6
Price$6.41
Change+$0.05 (+0.79%)
VolumeN/A
Net Assets846.46M
EIPCX vs SKRRX Comparison Chart in %
View a ticker or compare two or three
VS
EIPCX vs. SKRRX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EIPCX is a Hold and SKRRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
EIPCX has more cash in the bank: 2.64B vs. SKRRX (846M). EIPCX pays higher dividends than SKRRX: EIPCX (12.39) vs SKRRX (4.94). EIPCX was incepted earlier than SKRRX: EIPCX (15 years) vs SKRRX (10 years). SKRRX (0.94) is less costly to investors than EIPCX (0.67). SKRRX is a more actively managed with annual turnover of: 85.00 vs. EIPCX (0.00). SKRRX has a lower initial minimum investment than EIPCX: SKRRX (0) vs EIPCX (1000000). EIPCX annual gain was more profitable for investors over the last year : 24.14 vs. SKRRX (13.44). EIPCX return over 5 years is better than : 101.08 vs. SKRRX (56.67).
EIPCXSKRRXEIPCX / SKRRX
Total Expense Ratio0.670.8579%
Annual Report Gross Expense Ratio0.670.9471%
Fund Existence15 years10 years-
Gain YTD6.6376.89196%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.64B846M313%
Annual Yield % from dividends12.394.94251%
Returns for 1 year24.1413.44180%
Returns for 3 years39.0217.28226%
Returns for 5 years101.0856.67178%
Returns for 10 years181.07N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CING6.230.12
+1.96%
Cingulate Inc
TYRA31.240.22
+0.71%
Tyra Biosciences
XFOR4.000.02
+0.50%
X4 Pharmaceuticals Inc
CHSCM25.180.02
+0.08%
CHS
KRYS279.57-2.70
-0.96%
Krystal Biotech